On March 22, 2017, the Board of Directors of Repro Med Systems, Inc. (the “Company”) approved a change in the Company’s fiscal year end from February 28 to December 31. This change is being made by the Company to better align the Company’s financial reporting calendar with its industry peers, suppliers and customers. Accordingly, the Company will file its Form 10-K for the fiscal year ending February 28, 2017 in May 2017. For its new fiscal year ending December 31, 2017, it will file its Form 10-K for ten months ending December 31, 2017 and twelve months ending February 28, 2017 in March 2018. With this fiscal year end change, the Company will report one-time, transitional financial information for the month of March, 2017 and the quarter April through June 2017 on Form 10-Q in August 2017. The Company expects to make the fiscal year change on a prospective basis and will not adjust operating results for prior periods. The change to the Company’s fiscal year will not impact the Company’s fiscal year results for the year ended February 28, 2017.